Your browser doesn't support javascript.
loading
Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
Verhoeff, S R; van Erning, F N; Lemmens, V E P P; de Wilt, J H W; Pruijt, J F M.
Afiliação
  • Verhoeff SR; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
  • van Erning FN; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Eindhoven, The Netherlands.
  • Lemmens VE; Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
  • de Wilt JH; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Eindhoven, The Netherlands.
  • Pruijt JF; Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
Int J Cancer ; 139(1): 187-93, 2016 Jul 01.
Article em En | MEDLINE | ID: mdl-26914273
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Adenocarcinoma / Quimioterapia Adjuvante / Neoplasias do Colo Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prognóstico / Adenocarcinoma / Quimioterapia Adjuvante / Neoplasias do Colo Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda